Acorda Therapeutics Inc

NASDAQ ACORQ

Data sourced from iex and EODHD
Download Data

Acorda Therapeutics Inc Cash Flow Statement 2023 - 2024

This table shows the Cash Flow Statement for Acorda Therapeutics Inc going from 2023 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Net Income
M -27 -218 -9 -9 -17
Depreciation and Amortization
M 1 8 8 8 8
Non-Cash Items (Other)
M 12 3 0 4 3
Operating Cash Flow
M -20 -3 8 -12 -7
Capital Expenditures
M 0 0 0 0 0
Net Acquisitions
M - - - - -
Other Investing Activities
M - - - - -
Investing Cash Flow
M - - - - -
Repayment/Issuance of Debt (Net)
M - - - - -
Equity Repurchase (Common, Net)
M - - - - -
Dividends Paid
M - - - - -
Other Financial Activities
M - - - - -
Financing Cash Flow
M - - - - -
Exchange Rate Adjustment
M - - - - -
Beginning Cash
M 31 34 26 38 45
Ending Cash
M 10 31 34 26 38
Stock-Based Compensation
M 0 0 0 0 0
Issuance/Purchase of Shares
M - - - - -
Capital Stock Change
M - - - - -
Working Capital
M -175 -153 27 35 33
Free Cash Flow
M -20 -3 7 -12 -7

StockViz Staff

September 16, 2024

Any question? Send us an email